Track the 프레스티지바이오로직스 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 프레스티지바이오로직스 has published 47 public disclosures. The latest transaction was reported on 10 July 2026 (Purchase). Among the most active insiders: 프레스티지바이오파마. All data is accessible without an account.
47
Insider Decl.
n/a
Thresholds
n/a
39 ops.
Buy Volume
n/a
1 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.